Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) Transcript

Feb 09, 2022 / 06:30PM GMT
Release Date Price: $19.38 (+2.11%)
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

All right. Hello, and welcome. My name is Michael Schmidt. I'm a senior biotech analyst with Guggenheim Securities, and it's my great pleasure to welcome Michael Morrissey, President and CEO of Exelixis. Welcome, Michael, and thanks for joining us again this year.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Great to see you again virtually. Looking forward to doing this live, hopefully, next year.

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

Yes, we'll be ready.

Questions & Answers

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

So looking forward to it as well. So Michael, let's just jump right into questions and skip over the slide presentation. Cabo, as you all know, has generated over $1 billion in net sales in 2021 and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot